Norris Medicines Complete Financial Statements
NORRIS • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Norris Medicines (NORRIS).
Downloads include all available records across all periods.
For market performance, see the
NORRIS stock price today
.
Profitability Ratios
Net Profit Margin
-16.67%
2025 data
Operating Margin
-5.00%
2025 data
Return on Assets
-7.14%
2025 data
Balance Sheet Ratios
Current Ratio
0.32
2025 data
Equity Ratio
-107.14%
2025 data
Asset Turnover
0.43
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+16.7%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
Expense Growth
+33.3%
Year-over-Year
Equity Growth
-7.1%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 6 | 6 | 8 | 10 | 12 | 8 | 16 | 14 | 21 | 19 | 19 |
| Expenses | 8 | 6 | 6 | 7 | 10 | 14 | 10 | 17 | 16 | 21 | 18 | 17 |
| EBITDA | -1 | 0 | 0 | 1 | 0 | -2 | -2 | -1 | -2 | 0 | 1 | 2 |
| Operating Profit Margin % | -8.00% | -5.00% | -3.00% | 11.00% | -1.00% | -14.00% | -27.00% | -4.00% | -14.00% | 0.00% | 4.00% | 9.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -2 | -1 | -1 | -1 | -2 | -4 | -4 | -2 | -3 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 1 | 1 | 1 | -1 | 0 | -1 | 0 | 0 | 1 |
| Net Profit | -2 | -1 | -1 | -2 | -3 | -5 | -3 | -2 | -3 | -1 | 0 | -1 |
| Earnings Per Share (₹) | -1.50 | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 | -2.51 | -0.77 | 0.04 | -1.04 |
Related Pages for Norris Medicines
Additional stock information and data for NORRIS
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 14 | 14 | 14 | 14 | 20 | 21 | 20 | 21 | 22 | 18 | 18 |
| Current Assets | 6 | 6 | 5 | 4 | 8 | 7 | 7 | 8 | 9 | 7 | 7 |
| Fixed Assets | 5 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 8 | 9 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 9 | 8 | 7 | 7 | 12 | 12 | 12 | 11 | 12 | 10 | 10 |
| LIABILITIES | |||||||||||
| Total Liabilities | 14 | 14 | 14 | 14 | 20 | 21 | 20 | 21 | 22 | 18 | 18 |
| Current Liabilities | 19 | 19 | 18 | 18 | 16 | 15 | 11 | 8 | 8 | 8 | 8 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | -15 | -14 | -12 | -11 | -7 | -3 | 0 | 2 | 5 | 5 | 5 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -25 | -24 | -22 | -21 | -17 | -12 | -10 | -8 | -5 | -5 | -5 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1 | 0 | 1 | -1 | 1 | -3 | -2 | 1 | -1 | 1 | -1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | -1 |
| Financing Activities | -1 | 0 | -1 | 1 | -1 | 3 | 2 | -1 | 3 | -1 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 |